Melanocortin-4 receptor binding compounds and methods of use thereof
申请人:Millennium Pharmaceuticals, Inc.
公开号:US20040082779A1
公开(公告)日:2004-04-29
Provided are MC4-R binding compounds of the formula XVII:
1
wherein L
2
is a linker group, and P
1
, P
2
, P
3
, P
4
, Z
1
, Z
2
, Z
3
, Z
4
, Z
5
, t, s, and R are as described in the specification. Methods of using the compounds to treat MC4-R associated disorders, such as disorders associated with weight loss, are also provided.